A Quote by Mike Braun

I'm offering solutions to address rising healthcare prices by adding transparency to our drug pricing, clearing the backlog on pending drug applications at the FDA, and providing oversight and accountability within the healthcare industry.
The other kind of market like technology is healthcare. Nobody likes the healthcare industry, but on the other hand, everyone wants to live longer. The way I look at it, there's going to be tremendous pressure with healthcare as a percentage of GDP rising with new technology, an aging population, and a business model that basically keeps people alive longer to consume more healthcare products.
The value that the generic drug industry brings to the U.S. healthcare system is indisputable.
When the FDA forces an old drug off the market, patients have very little say in the matter. Patients have even less of a say when the FDA chooses not to approve a new drug. Instead, we are supposed to rely on the FDA's judgment and be grateful. But can the FDA really make a choice that is appropriate for everyone? Of course not.
We've got to get our drug industry back. Our drug industry has been disastrous. They're leaving left and right. They supply our drugs, but they don't make them here, to a large extent. And the other thing we have to do is create new bidding procedures for the drug industry because they're getting away with murder.
Quality Healthcare is a premier healthcare brand in Hong Kong and is the leading private healthcare provider there. We are believers in long-term growth prospects of the Asian healthcare space and the benefits of a world-class pan-Asian integrated healthcare delivery system.
I've always worked on bipartisans, whether it's on healthcare, drug reform, et cetera. All my work is bipartisan, because what I'm - as nonpartisan actually, because I look for solutions. I'm very practical.
Healthcare costs are rising, and not just Medicare and Medicaid, but healthcare in general.
The global healthcare industry is undergoing a paradigm shift, providing significant opportunities for Philips to deliver more integrated solutions across the continuum of care - from prevention, diagnosis, and treatment to monitoring and aftercare.
Republicans have offered dozens of comprehensive healthcare plans many of which achieve comprehensive healthcare reform without breaking what's working in healthcare. We want to fix what's broken in healthcare.
We use similar products. Our focus industry is healthcare and hospitality. But we haven?t done anything interactive. The first day full of seminars is full of things I thought would be useful: quick service restaurant and mobile phone applications. Businesses are providing more services and products by self-service means.
In case you haven't noticed, a large wall is being built around the American people to ensure that they remain prisoner to the drug industry. It's easy to understand why drug makers want to force Americans to buy their products in the United States. Ours is the only industrialized country that doesn't negotiate the prices the drug companies may charge. As a result, a 90-day supply of Fosamax sells for $105 in Canada but $210 here.
If you go to the FDA with a drug that's only meant to treat 50 people, and it's a 95 percent cure rate, you'll get your drug approved.
It is not enough to show that drug A is better than drug B on the average. One is invited to ask, 'For which people ("& why") is drug A better than drug B, and vice versa? If drug A cures 40% and drug B cures 60%, perhaps the right choice of drug for each person would result in 100% cures.'
Consider the clinicaltrials by which drugs are tested in human subjects.5 Before a new drug can enter the market, its manufacturer must sponsor clinicaltrials to show the Food and Drug Administration that the drug is safe and effective, usually as compared with a placebo or dummy pill. The results of all the trials (there may be many) are submitted to the FDA, and if one or two trials are positive—that is, they show effectiveness without serious risk—the drug is usually approved, even if all the other trials are negative.
Providing patients and consumers with solid information on the cost and quality of their healthcare options can literally make the difference between life or death; and play a decisive role in whether a family or employer can afford healthcare.
I've been an entrepreneur all my life, and my recent focus is on finding entrepreneurial solutions to address global challenges in healthcare and education.
This site uses cookies to ensure you get the best experience. More info...
Got it!